Home / News / Demand dicates that ABHI doubles its US ‘Innovation Hub’

Demand dicates that ABHI doubles its US ‘Innovation Hub’

The Association of British HealthTech Industries (ABHI) has taken another important step in supporting UK HealthTech companies do business in the US by doubling the capacity of their Innovation Hub. Following the success of the first cohort, another eight companies have joined.

The Hub is a unique partnership between ABHI, the UK’s health technology trade association, and the Dell Medical School at The University of Texas in Austin. Companies include: Firstkind Medical, Rightangled Diagnostics, Owen Mumford, Directed Systems, Virti, DCC Vital and Aleisi Surgical.

Each business will be able to work closely with leaders from The University of Texas, accessing Dell Med’s full range of facilities, innovation teams and faculty, whilst being supported by ABHI’s network of connections across Texas’ four major cities. They can also take advantage of ABHI’s highly developed HealthTech network, including investors, hospital systems, chambers of commerce and key business groups.

Another unique feature is access to a team of senior mentors who are on-hand to offer bespoke support, as well as ABHI’s dedicated year-round support and introductions across the US.

Located within Austin’s Health District, the Hub is a key base for UK companies as it is one of the city’s largest and most anticipated development projects. The district physically links Dell Medical School to its key partners, Seton Healthcare Family and Central Health and includes 600,000 square feet of space dedicated to innovative education, care and research.

The Innovation Hub is part of the ABHI’s broader US Accelerator programme which also includes two tailored trade missions to key US HealthTech hubs, developed to forge and develop partnerships with leading clinical communities.

Jackie Fielding, Regional Vice President for Medtronic and Vice Chair of the ABHI Board of Directors said: “We are deeply supportive of the work ABHI is doing to assist UK companies with their export strategies, and the ABHI Innovation Hub is a prime opportunity for businesses to develop operations stateside. On behalf of the ABHI Board, I am delighted with how well the US Accelerator Programme is going and we are proud to be developing these two-way trading partnerships.”

Ruben Rathnasingham, Assistant Dean for Health, Product Innovation at Dell Medical School added: “Since the launch of the ABHI Innovation Hub at Dell Med, we have met with, and learned from, numerous small and large UK businesses, academic medical centers and health systems. We have helped several UK-based businesses connect with key US market leaders and are also in active partnership discussions with UK-based start-ups who now have a presence in Austin. ABHI’s International Program, that supports US-based companies enter and explore the UK market, has been a further value-driver for our partnership.”

Companies involved in the first phase of the hub include: Lumeon, Forte Medical, Timesco, P3, Deltex Medical, Endomag and Deontics.

Visit the AHBI website here.

Check Also

Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.

Quotient Sciences, a leading drug development services organisation, announces a significant expansion to its operations …